Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

The document lists various dermatology topics, treatments, and diagnostic methods.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

The document concludes that injecting dutasteride into the skin (mesotherapy) can effectively treat common hair loss in both men and women.

Topical spironolactone works better than topical finasteride for hair loss.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

Minoxidil 2% is more effective for female hair loss, but botanicals have fewer side effects.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Contraceptive agents help with menstrual issues, acne, and other health conditions in teens.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.